210 related articles for article (PubMed ID: 19793807)
1. Evasion of the mucosal innate immune system by herpes simplex virus type 2.
Peng T; Zhu J; Klock A; Phasouk K; Huang ML; Koelle DM; Wald A; Corey L
J Virol; 2009 Dec; 83(23):12559-68. PubMed ID: 19793807
[TBL] [Abstract][Full Text] [Related]
2. A sustained type I IFN-neutrophil-IL-18 axis drives pathology during mucosal viral infection.
Lebratti T; Lim YS; Cofie A; Andhey P; Jiang X; Scott J; Fabbrizi MR; Ozantürk AN; Pham C; Clemens R; Artyomov M; Dinauer M; Shin H
Elife; 2021 May; 10():. PubMed ID: 34047696
[TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo.
Murphy JA; Duerst RJ; Smith TJ; Morrison LA
J Virol; 2003 Sep; 77(17):9337-45. PubMed ID: 12915549
[TBL] [Abstract][Full Text] [Related]
4. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
[TBL] [Abstract][Full Text] [Related]
5. OASL1 deficiency promotes antiviral protection against genital herpes simplex virus type 2 infection by enhancing type I interferon production.
Oh JE; Lee MS; Kim YJ; Lee HK
Sci Rep; 2016 Jan; 6():19089. PubMed ID: 26750802
[TBL] [Abstract][Full Text] [Related]
6. Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2.
Milligan GN
J Virol; 1999 Aug; 73(8):6380-6. PubMed ID: 10400730
[TBL] [Abstract][Full Text] [Related]
7. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
Gill N; Rosenthal KL; Ashkar AA
J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
[TBL] [Abstract][Full Text] [Related]
8. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2.
Zhao X; Deak E; Soderberg K; Linehan M; Spezzano D; Zhu J; Knipe DM; Iwasaki A
J Exp Med; 2003 Jan; 197(2):153-62. PubMed ID: 12538655
[TBL] [Abstract][Full Text] [Related]
9. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
Bagri P; Anipindi VC; Nguyen PV; Vitali D; Stämpfli MR; Kaushic C
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956763
[TBL] [Abstract][Full Text] [Related]
10. Herpes Simplex Virus Type 2 Immediate Early Protein ICP27 Inhibits IFN-β Production in Mucosal Epithelial Cells by Antagonizing IRF3 Activation.
Guan X; Zhang M; Fu M; Luo S; Hu Q
Front Immunol; 2019; 10():290. PubMed ID: 30863402
[TBL] [Abstract][Full Text] [Related]
11. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.
Milligan GN; Bernstein DI
Virology; 1995 Oct; 212(2):481-9. PubMed ID: 7571418
[TBL] [Abstract][Full Text] [Related]
12. The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice.
Parr MB; Parr EL
Virology; 1999 Jun; 258(2):282-94. PubMed ID: 10366565
[TBL] [Abstract][Full Text] [Related]
13. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2.
Milligan GN; Bernstein DI; Bourne N
J Immunol; 1998 Jun; 160(12):6093-100. PubMed ID: 9637526
[TBL] [Abstract][Full Text] [Related]
14. Tissue-Resident-Memory CD8
Peng T; Phasouk K; Sodroski CN; Sun S; Hwangbo Y; Layton ED; Jin L; Klock A; Diem K; Magaret AS; Jing L; Laing K; Li A; Huang ML; Mertens M; Johnston C; Jerome KR; Koelle DM; Wald A; Knipe DM; Corey L; Zhu J
Front Immunol; 2021; 12():735643. PubMed ID: 34552595
[TBL] [Abstract][Full Text] [Related]
15. Type I interferon production during herpes simplex virus infection is controlled by cell-type-specific viral recognition through Toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems.
Rasmussen SB; Sørensen LN; Malmgaard L; Ank N; Baines JD; Chen ZJ; Paludan SR
J Virol; 2007 Dec; 81(24):13315-24. PubMed ID: 17913820
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of B7 expression by herpes simplex virus antigen.
Singh R; Kumar A; Diaz-Mitoma F
Hum Immunol; 2003 Aug; 64(8):780-6. PubMed ID: 12878356
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus-2 in the genital mucosa: insights into the mucosal host response and vaccine development.
Lee AJ; Ashkar AA
Curr Opin Infect Dis; 2012 Feb; 25(1):92-9. PubMed ID: 22143115
[TBL] [Abstract][Full Text] [Related]
18. Immunoregulatory Functions of Interferons During Genital HSV-2 Infection.
Feng E; Balint E; Vahedi F; Ashkar AA
Front Immunol; 2021; 12():724618. PubMed ID: 34484233
[TBL] [Abstract][Full Text] [Related]
19. Enrichment of herpes simplex virus type 2 (HSV-2) reactive mucosal T cells in the human female genital tract.
Posavad CM; Zhao L; Dong L; Jin L; Stevens CE; Magaret AS; Johnston C; Wald A; Zhu J; Corey L; Koelle DM
Mucosal Immunol; 2017 Sep; 10(5):1259-1269. PubMed ID: 28051084
[TBL] [Abstract][Full Text] [Related]
20. Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes.
Schiffer JT; Abu-Raddad L; Mark KE; Zhu J; Selke S; Koelle DM; Wald A; Corey L
Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18973-8. PubMed ID: 20956313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
